SoftBank China Venture Capital returned for a $42.3m round that will support the international growth of Huilianyi's expenses management software.
The data management software provider has now secured a total of $115m, Cisco Investments returning to back its latest round.
The edible protein developer has rebranded from Sustainable Bioproducts and received series B funding from investors including existing backers Danone and Archer Daniels Midland.
Lilly Asia Ventures, an investor in the cancer drug developer since its series A round, returned to back a series C that doubled its overall funding to $140m.
SR One led a round disclosed by the genetic medicine developer, a spinout of University of Wisconsin-Madison, as it emerged from stealth.
Eli Lilly took part in an $80.3m round that pushed chronic illness drug developer Sigilon Therapeutics' overall funding to nearly $200m.